Skip to content

A randomized controlled trial for comparing ceramic bone graft versus allograft, and autograft in lumbar fusion for degenerative spinal disorders

A randomized controlled trial for comparing ceramic bone graft versus allograft, and autograft in lumbar fusion for degenerative spinal disorders

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036062
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-08-28
Completion date
Unknown
Last updated
2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

degenerative lumbar disorders

Interventions

A:The cage was filled with local autogenous bone, the intervertebral space was filled with ceramic bone, and the posterolateral bone graft surface was mixed with local autogenous bone and ceramic bone
B:The cage was filled with local autogenous bone, the intervertebral space was filled with allograft bone, and the posterolateral bone graft surface was mixed with local autogenous bone and allograft
C:The cage and intervertebral space were filled with local autogenous bone, and the posterolateral bone graft surface was mixed with local autogenous bone and allograft bone.

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-80 years with single or double segment TLIF(PLIF) for degenerative lumbar disorders; 2. Patients were diagnosed as degenerative spondylolisthesis, lumbar instability and lumbar spinal stenosis.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of spinal surgery; 2. Bone densitometer confirms T value <=-2.5 for osteoporosis; 3. Hormone drugs were used; 4. Patients were diagnosed as spondylolysis spondylolisthesis, spinal tuberculosis, primary or metastatic spinal tumors and spinal trauma.

Design outcomes

Primary

MeasureTime frame
Fusion rate;Bone graft volume fraction;

Secondary

MeasureTime frame
ODI score;VAS score;EQ-5D-5L score;

Countries

China

Contacts

Public ContactXi Yang

West China Hospital, Sichuan University

yangxi_cd@163.com+86 18980606893

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026